Short answers with sources
TB-500 is a short protein piece, and many claims outrun the facts.
This page answers common questions about safety, steroids, BPC-157, study results, FDA rules, and sports bans.
The name belongs to one short piece of a larger protein
What exactly is TB-500?
TB-500 is a short piece of protein made in a lab. Its seven parts match parts 17–23 of thymosin beta-4. At that spot, the parent protein holds actin so cells can keep their form and move [1]. Labs and animal doctors study the fragment, but it isn't an approved medicine. That is its product name.
How did TB-500 get the TB name, and what does TB-500 refer to?
The letters TB point back to thymosin beta-4. Scientists use TB-500 as the lab and animal-work name for one man-made piece of thymosin beta-4 [1]. The letters and number form a product name. They do not name each small protein part.
Why do researchers study TB-500?
Scientists study thymosin beta-4 and the actin-gripping part. They watch cells move, wounds close, blood vessels grow, and heart or brain harm change. They also check hair roots, swelling, and scars [5]. These are study questions, not approved uses. The best results concern the full protein.
How might TB-500 work?
TB-500 includes the section of thymosin beta-4 that stores loose actin for cells [1]. Tests after injury found that the complete protein moved cells, grew blood vessels, eased swelling, kept cells alive, and reduced scars [5]. Careful tests in people have not linked all those results to the fragment [5].
Is TB-500 a steroid or a peptide?
No. TB-500 is a peptide, which means a small protein piece. A steroid, such as cortisone, is another type of substance. The seven-part TB-500 piece comes from thymosin beta-4 [1]. Its protein parts and the way it holds actin are unlike a steroid [5].
Human side effects and long-term safety remain unknown
Which side effects are known for TB-500?
Human safety work on the fragment is very thin. The main worry is that full thymosin beta-4 could aid tumor growth while making new blood vessels [5]. In Phase 1, an early safety trial gave people up to 1260 mg of the thymosin beta-4 protein by vein. Side effects were usually no worse than mild or moderate, and each dose continued [6]. This short test gives you no firm answer about long use of the fragment.
Could TB-500 help a cancer grow?
The answer is not settled. Thymosin beta-4 appears at raised levels in some cancers, and lab studies tie the protein to spreading cancer and added blood vessels [5]. Those actions can aid wound repair, yet a tumor might use them too. Human work has proved neither harm nor safety for the small piece.
Do we know whether long-term TB-500 use is safe?
No human safety study has followed TB-500 for the long term [5]. Cancer questions remain, and no completed fair trial has cleared up long use [5]. The lone human safety test covered 14 days and gave the whole protein by vein [6]. It did not test the small piece you are asking about.
The short chain differs from other repair peptides and has no drug approval
How are TB-500 and BPC-157 different?
TB-500 comes from one small section of thymosin beta-4. BPC-157 has its own man-made chain [1]. They are separate compounds, even though repair studies mention both. A 2026 Sports Medicine review placed both among unapproved peptides used for injured muscles and joints [10].
Do sports drug rules ban TB-500?
Yes. WADA bars TB-500 and thymosin beta-4 while you compete and between events [5]. The rule covers small protein drugs, growth aids, and tissue-repair drugs. A lab can detect either form. A 2024 test measures TB-500 and the material that remains after it breaks apart [15]. If drug rules cover your sport, the ban applies at all times.
Has FDA approved TB-500 for human use?
No. FDA has not approved TB-500 as a medicine for people [19]. The agency once put the thymosin beta-4 piece in Category 2 under pharmacy rule 503A. That group is for raw drugs with serious safety concerns. FDA now lists the 2023 request as withdrawn [18]. Lab or animal work does not make TB-500 an approved drug.
What parts of TB-500's legal status are clear?
TB-500 has no FDA drug approval, though research sellers offer it to labs [19]. The thymosin beta-4 piece once sat in Category 2 under FDA pharmacy rule 503A. That group flags raw drugs that could bring grave safety trouble. FDA's page dated April 22, 2026 places the request among withdrawn ones but does not name who withdrew it. Pharmacies using 503A have no FDA answer about what follows [18]. Sports rules also bar the compound [5]. This isn't legal advice.
May a compounding pharmacy make TB-500?
FDA's current page puts the TB-500 request outside Category 2 and calls it withdrawn. That group covers raw drugs FDA sees as a grave safety risk. The agency does not explain whether normal use under pharmacy rule 503A is lawful now [18][19]. Usually, a doctor meets the patient and may write that person's prescription. A 503A pharmacy can prepare that medicine. A 503B site can prepare bigger clinic batches. Both must use raw drugs allowed by law [19].
What does FDA's 503A one-patient pharmacy page say about TB-500?
FDA calls TB-500 a small piece of thymosin beta-4. Its September 29, 2023 update placed the drug in Category 2 under pharmacy rule 503A. FDA warned that it might wake an immune response and that needed safety facts were absent. The page current as of April 22, 2026 now puts the request among withdrawn ones [18]. FDA's pharmacy advisers discussed it on July 23–24, 2026. Their meeting settled nothing, and FDA has posted no vote count [17].
Animal findings are stronger than human proof
Have controlled human trials tested TB-500 itself?
Researchers have not finished a controlled human test of the TB-500 seven-part piece [5]. Human studies gave full thymosin beta-4 instead. A Phase 1 vein trial, an early safety test, watched side effects and time in the blood [6]. Eye drops called RGN-259 reached dry-eye trials [7]. A shot after a sudden heart attack finished another trial [8]. An early heart-attack shot test was withdrawn before anyone joined [9].
What newer work covers TB-500 or thymosin beta-4?
Work from 2021–2026 asked several questions. A 2025 wound gel held the full protein inside tiny sacs made by cells [12]. Another 2025 test paired the protein with selenium for diabetic sores [13]. A third 2025 team linked small protein pieces for eye wounds [16]. A 2024 drug check measured the small piece [15]. In 2026, Sports Medicine reviewed unapproved peptides used after muscle and joint injury [10].
Why do scientists call thymosin beta-4 an exercise factor?
A 2021 study found thymosin beta-4 entering people's blood during exercise [11]. Put plainly, their bodies released the protein while they were active. The protein also helps cells grow. Those facts are one reason scientists study sports recovery. They do not show that giving TB-500 would improve your recovery.
Has TB-500 been shown to heal muscle tears?
Animal tests found thymosin beta-4 drawing young muscle cells toward injured tissue. Mice born with a disease that wastes muscle grew new fibers, yet stayed just as weak [5]. No benefit has been proved in people. Exercise does release the complete protein into human blood [11]. That fact calls for more study, but it can't promise you a faster recovery.
How soon might TB-500 affect an injury?
Researchers have not measured the wait in people. Rats with wounds through the skin received full thymosin beta-4. New skin cover was 42% higher at 4 days and up to 61% higher at 7 days [3]. Since rats received the complete protein, the result cannot set a TB-500 time for you.
Do studies show TB-500 healing a tendon or ligament?
Researchers injured a rat's knee ligament, then saw more repair after thymosin beta-4 [5]. Few direct studies sit behind the sports-recovery claim. A good human trial has not shown the small piece mending a tendon or ligament. The claim rests on animal work and the full protein's effects on moving cells and scars [5].
What did heart studies of TB-500's parent protein find?
In mice with a tied heart artery, thymosin beta-4 kept young heart cells alive and made the heart work better [2]. The study traced several steps inside the cells. Testing in pigs showed no help after blood flow returned. A separate human trial tested thymosin beta-4 after a sudden heart attack [8]. The mouse gain hasn't become a proved result for people using the fragment.
Did TB-500's parent protein help the brain after stroke?
Rats with a clot-caused stroke moved better after full thymosin beta-4 at 2 and 12 milligrams per kilogram of each rat's weight. The amount of 18 milligrams per kilogram brought no help. From those tested amounts, a math estimate favored about 3.75 milligrams per kilogram, though researchers did not test it [4]. Each amount came by a belly shot. An animal result can't prove that TB-500 protects your brain.
What wound results are tied to TB-500?
Animal and surface tests found thymosin beta-4 helping skin and eye wounds close. The work raised collagen, formed blood vessels, and moved skin cells at just 10 picograms [3]. Newer teams carried the protein in tiny cell-made sacs inside gels [12] or linked small protein pieces [16]. No human wound trial has proved that TB-500 helps you heal [5].